ITEMS IN AFP WITH KEYWORD:

Gout

May 15, 2010 Issue
Febuxostat (Uloric) for Hyperuricemia and Gout [STEPS]

Febuxostat more effectively lowers serum uric acid to goal levels than does allopurinol; however, this benefit is offset by a slightly higher incidence of adverse effects and treatment discontinuation. Until superiority for patient-oriented outcomes is shown in comparative trials with allopurinol, f...


Sep 15, 2007 Issue
Gout: An Update [Article]

Arthritis caused by gout (i.e., gouty arthritis) accounts for millions of outpatient visits annually, and the prevalence is increasing. Gout is caused by monosodium urate crystal deposition in tissues leading to arthritis, soft tissue masses (i.e., tophi), nephrolithiasis, and urate nephropathy. The...


Apr 1, 1999 Issue
Diagnosis and Management of Gout [Article]

Gout is a disease resulting from the deposition of urate crystals caused by the overproduction or underexcretion of uric acid. The disease is often, but not always, associated with elevated serum uric acid levels. Clinical manifestations include acute and chronic arthritis, tophi, interstitial renal...


Feb 15, 1999 Issue
Gout and Hyperuricemia [Article]

Gout is a condition characterized by the deposition of monosodium urate crystals in the joints or soft tissue. The four phases of gout include asymptomatic hyperuricemia, acute gouty arthritis, intercritical gout and chronic tophaceous gout. The peak incidence occurs in patients 30 to 50 years old, ...


Pages: Previous 1 2


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now